Radionuclides4HealthUK

Official account for Radionuclides for Health UK
Connecting academia, industry and government to establish UK production of radionuclides for cancer treatment

[Radionuclides4HealthUK @RadionuclidesUK]

@MHRAgovuk announced today they will be changing legislation for diagnostic radiopharmaceuticals making it simpler for them to be used in clinical trials.

[MHRAgovuk @MHRAgovuk]

We're working with support from partners to make it faster and easier to gain approval and to run #clinicaltrials in the UK. This is the biggest overhaul in UK clinical trials #regulation in over 20 years 👉 https://t.co/fRmaGaaowT

[RSC Radiochemistry Group @RSC_Radiochem]

Radionuclide Production in the UK
@RadionuclidesUK
📢Registration and abstract submission are now open!
https://t.co/qi4KBck87H
📅18 October 2023
📍Governors Hall, St Thomas' Hospital, London.

[RSC Radiochemistry Group @RSC_Radiochem]

☢️Radiochemistry Group New Researchers Meeting 2023!

Join us in Sheffield on the 20-21st July.

NRM is a fantastic opportunity for PhD students and early career researchers to present their work at a national conference and network with their peers!
1/3

#AnywhereChem #Radiochem

[Paul Monks @psmonks]

Around 700,000 nuclear medicine procedures using radionuclides are performed each year in the UK. The Medical Radionuclide Innovation Programme (MRIP) up to £4m Innovation Project Call will support the development of technologies and techniques. https://t.co/xLv3hf9FCY

[Paul Monks @psmonks]

The Medical Radionuclide Innovation Programme Innovation Project Call is now open. Providing up to £4 million worth of funding to support the development of technologies and techniques to enable future access to medical radionuclides. https://t.co/xLv3hfadsw (Image @sciam)

[Samantha Terry (she/her) @syaterry]

Finally the news is more official, I am now an @KingsImaging @The_MRC New Investigator Research Fellow on an exciting project with alpha particle-emitters working with @Viewpoint_MT at Perspective Therapeutics through @RadNetCRUKCoL @RadionuclidesUK

https://t.co/ZB9DltdGYe

[Michael Hofman @DrMHofman]

Another extraordinary day at @PeterMacCC. We gave cycle #17 of Lu-177 PSMA-617 to a patient with prostate cancer. Continues to benefit 4+ years. Bloods and renal function normal.
Even more extraordinary, We were both wearing the same socks. @pros_tic

[Samantha Terry (she/her) @syaterry]

That was an exhilarating talk with Jen from @RadionuclidesUK @KingsImaging with people at the Dutch Embassy around the exciting future of using radioactivity to treat cancer and the reactors that are needed to make this happen!!

[European Association of Nuclear Medicine (EANM) @EANM_NucMed]

Happy to announce publication of @EAHPtweet –#EANM joint statement on availability of radiopharmaceuticals in context of revision of pharmaceutical legislation. Check out our policy recommendations on a flexible regulatory framework for low-volume products.https://t.co/oh8BFnuJ6h

[Radionuclides4HealthUK @RadionuclidesUK]

We support this joint statement @EAHPtweet and @officialEANM - radiopharmaceutical availability for patients should be the priority.

[European Association of Hospital Pharmacists @EAHPofficial]

Together with @officialEANM we have issued a Joint Statement on the availability of radiopharmaceuticals in the context of the revision of the general pharmaceutical legislation! You can read it here 👉 https://t.co/114mNCl2Al

#HPcare4U

[Radionuclides4HealthUK @RadionuclidesUK]

Nuclear legacy material isn't just useful for #NuclearMedicine applications and #CancerResearch it can also be used to power #space batteries!
@SpaceParkLeic

@UKNNL are pioneering new and exciting ways to use nuclear legacy material - keep up the fantastic work!

[United Kingdom National Nuclear Laboratory @UKNNL]

Read more about our collaboration with @spacegovuk on the world's first space battery powered by British fuel, Americium-241 in The Times. #NuclearSciencetoBenefitSociety

[Paul Monks @psmonks]

Trip to @UniOfHull @HullHospitals @DaisyAppeal reinforces how vital medical radionuclides and their applications are in NHS services, such as in diagnostic imaging and cancer therapy

[Department for Science, Innovation and Technology @SciTechgovuk]

Yesterday, Chief Scientific Advisor @psmonks visited @HuMIC_ to launch a £6m Medical Radionuclide Innovation Programme – a new scheme developing technologies which will produce nuclear materials for diagnostics and cancer therapies #InnovationNation

[SNMMI @SNM_MI]

There will be a shortfall in Mo-99 production—and hence a shortage of Mo-99/Tc-99m generators—through late November of this year. Check the Advocacy/Radiopharmaceutical Supply News page on the SNMMI website for the latest updates. https://t.co/ySxjbUE4Es #NuclearMedicine

[Radionuclides4HealthUK @RadionuclidesUK]

It's World Radiography Day - thank you to #radiographers for the vital work you do. @SCoRMembers

We're proud to work in radiation research
@RadNetCRUKCoL @KingsImaging @QMBCI

[Radionuclides4HealthUK @RadionuclidesUK]

Right now there are shortages of the radioactive components essential for #NuclearMedicine drugs (Tc-99m, I-131 and Tl-201) and this is impacting #NHS patients.

We call on the government to secure supply for the UK

https://t.co/l6KpUXplhW

[Dr Heather Williams MBE @alrightPET]

Our chief radiopharmacist has called this the worst Mo99 shortage in a decade - it will have a marked impact on Nuclear Medicine tests using Tc99m (a decay product of Mo99) over the next three weeks.

[SNMMI @SNM_MI]

Mo-99 and I-131 shortages are expected through and beyond the third week of November due to a delay in restarting the BR2 reactor after scheduled maintenance. https://t.co/MYKCp7bzDj
#NuclearMedicine

[bnmsnews @BNMSnews]

The BNMS guidance has been updated today with some minor changes, including updated information on generator deliveries:https://t.co/CXYmk3Ri9w
@RCRadiologists @IPEM_NM_SIG @bnmsrtn @BIR_News @SRP_UK @SNM_MI @SCoRMembers @RoySocMed

[bnmsnews @BNMSnews]

The BNMS have issued guidance for departments in relation to the global shortage of molybdenum availability. View here
https://t.co/qTN7ICTKTi
@RCRadiologists @IPEM_NM_SIG @bnmsrtn @BIR_News @SRP_UK @SNM_MI @SCoRMembers @RoySocMed